Private Equity

China's Gan & Lee partners with JW Pharmaceutical to launch its novel bi-weekly GLP-1 drug, Bofanglutide, into the competitive South Korean market.

A $60M project in Union City gets the green light to bury CO2, promising economic boons and sparking debate on the future of green technology.

In a tough fundraising climate, Court Square's oversubscribed Fund V signals strong investor confidence in its 47-year track record and middle-market strategy.

Leo has merged Academy Locksmith and Firstline Lock and Door, creating Academy Access Solutions, a new national leader in integrated commercial security.

Velocity, a leader in re-engineered classics, partners with TRP Capital Partners, signaling a new era of growth for the booming restomod market.

A landmark agreement secures massive gas engine capacity, aiming to satisfy the voracious energy demands of the AI boom and stabilize fragile power grids.

Two former finance professionals launch Aces Wilder, a brand aiming to solve the modern man's wardrobe crisis with a tech-infused 'Social Uniform'.

A new employer-designed program offers free leadership training and a degree pathway to tackle Colorado's critical construction workforce shortage.

The ServiceNow consulting firm forms a powerhouse advisory board to fast-track its enterprise ambitions and race towards coveted Elite Partner status.

For the third straight year, Agape Care Group is a top US workplace. We explore how their employee-first strategy is setting a new standard for patient care.

EoS Fitness is buying and building gyms at a record pace. We look at the strategy, the money, and the impact on the competitive fitness landscape.

The acquisition of Prime Care Technologies and Prime Cloud positions DAS Health to solve critical IT and cybersecurity challenges in the senior living sector.

New federal data validates a high-grade rare earth deposit in Montana, a critical step in the US race to break China's grip on strategic minerals.

Enterprise Products Partners raises its distribution and buys back shares, showcasing financial strength ahead of key industry and earnings forecasts.

With a massive $600M credit facility, Phoenix Service Partners is set to expand its low-emission gas compression fleet in key US energy basins.

Transom Capital Group appoints Luke Dauch, a decade-long J.P. Morgan banker, to bolster its deal origination in a competitive middle-market landscape.

Karl Blackburn, former head of Quebec’s top employers’ council, takes the helm at the Montreal Heart Institute Foundation, signaling a new era.

A new program offers Northern California homeowners rebates and monthly payments to install home batteries, countering recent solar policy shifts.

AllRock Bio has begun a Phase 2a trial for its novel drug ROC-101, testing it in combination with new standard-of-care therapies for pulmonary hypertension.

Four portfolio companies of Oridian Capital Partners land on Inc. 5000's fastest-growing lists, revealing a potent strategy for scaling middle-market firms.